CHIT1 Gene (Chitinase 1)

CHIT1 Gene (Chitinase 1)

<div class="infobox infobox-gene">

| Property | Value |
|----------|-------|
| Gene Symbol | CHIT1 |
| Full Name | Chitinase 1 |
| Synonyms | Chitotriosidase, CHIT |
| Chromosomal Location | 1q32.1 |
| NCBI Gene ID | 1118 |
| OMIM | 607203 |
| Ensembl ID | ENSG00000133093 |
| UniProt | Q01228 |
| Protein Name | Chitinase-1 (Chitotriosidase) |
| Associated Diseases | Alzheimer's Disease, Parkinson's Disease, Gaucher Disease, ALS, Multiple Sclerosis |

</div>

Overview

CHIT1 (Chitinase 1), also known as chitotriosidase, encodes a hydrolytic enzyme that degrades chitin, a polymer of N-acetylglucosamine found in fungal cell walls, insect exoskeletons, and some parasites. While humans do not produce endogenous chitin, CHIT1 is expressed at high levels by [activated macrophages](/cell-types/macrophages) and [microglia](/cell-types/microglia), making it a sensitive marker of immune cell activation in various disease contexts[@bussel1995][@malaguarnera2019].

CHIT1 Gene (Chitinase 1)

<div class="infobox infobox-gene">

| Property | Value |
|----------|-------|
| Gene Symbol | CHIT1 |
| Full Name | Chitinase 1 |
| Synonyms | Chitotriosidase, CHIT |
| Chromosomal Location | 1q32.1 |
| NCBI Gene ID | 1118 |
| OMIM | 607203 |
| Ensembl ID | ENSG00000133093 |
| UniProt | Q01228 |
| Protein Name | Chitinase-1 (Chitotriosidase) |
| Associated Diseases | Alzheimer's Disease, Parkinson's Disease, Gaucher Disease, ALS, Multiple Sclerosis |

</div>

Overview

CHIT1 (Chitinase 1), also known as chitotriosidase, encodes a hydrolytic enzyme that degrades chitin, a polymer of N-acetylglucosamine found in fungal cell walls, insect exoskeletons, and some parasites. While humans do not produce endogenous chitin, CHIT1 is expressed at high levels by [activated macrophages](/cell-types/macrophages) and [microglia](/cell-types/microglia), making it a sensitive marker of immune cell activation in various disease contexts[@bussel1995][@malaguarnera2019].

The discovery of elevated chitotriosidase activity in the plasma and tissues of patients with [Gaucher disease](/diseases/gaucher-disease) established CHIT1 as an important biomarker for lysosomal storage disorders and macrophage-driven inflammation. Subsequently, elevated CHIT1 levels have been documented in [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), [amyotrophic lateral sclerosis](/diseases/amyotrophic-lateral-sclerosis), and other neurodegenerative conditions, reflecting the central role of microglial activation in these disorders[@aerts2011][@watowich2016].

Molecular Biology

Gene Structure

The human CHIT1 gene is located on chromosome 1q32.1 and consists of 12 exons spanning approximately 6.5 kb of genomic DNA. The gene encodes a protein of 466 amino acids with a molecular weight of approximately 50 kDa.

Protein Structure and Function

Chitotriosidase is a member of the family 18 chitinases, which are found in bacteria, plants, and animals:

Domain Architecture:

Catalytic Mechanism:

• Uses a substrate-assisted mechanism
• Hydrolyzes β-1,4 linkages in chitin
• Activity requires the conserved catalytic residues (D-X-D-X-D-X-E)
• Optimal pH is acidic (pH 5.0-6.0)

Enzyme Activity

Substrate Specificity:

• Chitotriosidase efficiently degrades chitin
• Also hydrolyzes chito-oligosaccharides
• Activity measured using synthetic substrates (4-methylumbelliferyl chitotrioside)
• One unit of activity = 1 nmol substrate hydrolyzed per hour per mL

• Tightly regulated at transcriptional level
• Induced by macrophage activation
• Stimulated by interferon-gamma and other cytokines
• Constitutive expression in certain tissues

Biological Functions

Immune Response

CHIT1 plays a role in host defense against chitin-containing pathogens:

Pathogen Defense:

• Defense against fungal infections
• Response to insect parasites
• Macrophage activation marker

• CHIT1 reflects immune cell activation state
• Secreted by activated macrophages
• Can be detected in blood and CSF

Microglial Activation Marker

In the central nervous system, CHIT1 serves as a marker of microglial activation[@watowich2016][@schoon2019]:

Microglial Biology:

• Resting microglia express low CHIT1
• Activated microglia upregulate CHIT1 dramatically
• CHIT1 used to track neuroinflammation in disease

• PET ligands targeting CHIT1 in development
• Potential for in vivo visualization of microglial activation
• Complementary to TSPO imaging

Role in Neurodegeneration

Alzheimer's Disease

CHIT1 is elevated in AD and serves as a biomarker of disease progression[@aerts2011][@jiang2019][@sofi2022]:

Biomarker Evidence:

• Elevated CHIT1 in AD patient plasma
• Higher levels correlate with disease severity
• CHIT1 increases with disease progression
• Independent of ApoE status

• Reflects chronic neuroinflammation
• Associated with amyloid pathology
• Links to tau pathology

• CHIT1 as readout of microglial burden
• Associated with cognitive decline
• Correlates with brain atrophy

Animal Models:

• CHIT1 elevated in mouse AD models["@bruning2021"]
• Microglial CHIT1 increases with age
• Correlates with amyloid burden

Parkinson's Disease

CHIT1 is also elevated in PD, reflecting ongoing microglial activation[@chen2020][@van2016]:

Biomarker Evidence:

• Elevated CHIT1 in PD patient plasma and CSF
• Levels correlate with disease severity
• Progressive increase over disease course
• Associated with motor symptoms

• Microglial activation in substantia nigra
• Chronic neuroinflammation
• Correlates with dopaminergic degeneration

Amyotrophic Lateral Sclerosis

CHIT1 has been studied as a biomarker in ALS[@kelley2019][@gonzalez2020]:

Evidence:

• Elevated CHIT1 in ALS patients
• Higher levels correlate with faster progression
• Reflects microglial activation in motor cortex
• Potential for disease monitoring

Other Neurodegenerative Disorders

Multiple Sclerosis:

• CHIT1 as marker of microglial activation
• Elevated in active disease
• Correlates with lesion activity

• Elevated CHIT1 in HD patients[@hall2018]
• Reflects microglial pathology
• Potential biomarker

• CHIT1 elevation documented[@kuo2022]
• Reflects neuroinflammation

Expression Pattern

Tissue Distribution

| Tissue | Expression Level | Cell Type |
|--------|-----------------|-----------|
| Spleen | Very high | Macrophages |
| Liver | High | Kupffer cells |
| Lung | High | Alveolar macrophages |
| Brain | Moderate-high | Microglia |
| Bone marrow | Moderate | Monocytes/macrophages |

Brain Expression

In the central nervous system:

• Microglia: Primary source in brain
• Localized to: Cortex, hippocampus, substantia nigra
• Activation-dependent: Low in resting, high in activated

Cellular Localization

• Secreted: Primary extracellular localization
• Lysosomal: Processed through secretory pathway
• Activity: Detected in plasma, CSF, and tissue

Biomarker Applications

Clinical Utility

CHIT1 has several advantages as a biomarker[@malaguarnera2019]:

Advantages:

• Easily measured in plasma/CSF
• Stable under storage conditions
• Detectable with standard assays
• Reflects disease activity

• Not disease-specific
• Variability between individuals
• Genetic deficiency in some populations (10-15%)

Diagnostic Use

• Screening for Gaucher disease (first-line test)
• Monitoring treatment response in lysosomal storage diseases
• Tracking disease progression in neurodegeneration

Therapeutic Monitoring

• Response to anti-inflammatory therapies
• Target engagement for microglial modulators
• Disease progression tracking

Therapeutic Implications

Targeting CHIT1

Modulating CHIT1 may have therapeutic benefit:

Small Molecule Inhibitors:

• Development of chitinase inhibitors
• Reducing neuroinflammation
• Clinical trials in development

• Anti-CHIT1 antibodies
• Gene therapy approaches

Biomarker-Driven Trials

• Using CHIT1 for patient selection
• Monitoring treatment response
• Dose-finding studies

Genetic Considerations

Common Polymorphisms

A common null polymorphism (duplication of CHIT1 exon 10) results in complete absence of enzymatic activity in 10-15% of the population. This must be considered when interpreting CHIT1 measurements.

Mutation Spectrum

• Missense mutations reduce activity
• Null alleles cause CHIT1 deficiency
• No severe clinical phenotype in homozygotes

See Also

• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
• [Gaucher Disease](/diseases/gaucher-disease)
• [Microglia](/cell-types/microglia-neuroinflammation)
• [Neuroinflammation](/mechanisms/neuroinflammation)
• [Microglial Activation](/mechanisms/microglial-activation)
• [Biomarkers](/mechanisms/neurodegeneration-biomarkers)

External Links

• [Ensembl: ENSG00000133093](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000133093)
• [NCBI Gene: CHIT1](https://www.ncbi.nlm.nih.gov/gene/1118)
• [UniProt: Q01228](https://www.uniprot.org/uniprot/Q01228)
• [GeneCards: CHIT1](https://www.genecards.org/cgi-bin/carddisp.pl?gene=CHIT1)
• [OMIM: 607203](https://omim.org/entry/607203)
• [Allen Brain Atlas: CHIT1](https://human.brain-map.org/microarray/search/show?search_term=CHIT1)

References

Pathway Diagram

The following diagram shows the key molecular relationships involving CHIT1 Gene (Chitinase 1) discovered through SciDEX knowledge graph analysis: